Baijin Life Science Holdings Limited
MNNGF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$134.94M
Close$
$-0.11
172.2% downside
Current Fair Value
172.2% downsideOvervalued by 172.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $134.94 Million |
|---|---|
| Enterprise Value | $123.51 Million |
| Earnings per Share | $-0.04 |
| Beta | -0.32 |
| Outstanding Shares | 899,576,000 |
Return
| Return on Equity | -20.62% |
|---|---|
| Return on Assets | -14.44% |
| Return on Invested Capital | -17.01% |
Valuation & Multiples
| P/E Ratio | -30.21 |
|---|---|
| PEG | 3.89 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.55 |
| Enterprise Value to EBIT | -3.64 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Baijin Life Science Holdings Limited
84 employees
CEO: Sze Ming Cheung
Affluent Partners Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including the...